New Jersey's new law will expand health insurance coverage for infertility services to now include LGBTQ+ individuals....

More than 8 in 10 cases of COVID-19 are now estimated to be the JN.1 variant....

History is made in Cameroon as the first doses of a malaria vaccine are rolled out in a widespread, international mass-vaccination effort....

CBS News chief medical correspondent Dr. Jon LaPook explains PSA tests and the process of diagnosing and treating ailments such as benign prostatic hyperplasia and prostate cancer....

GLP-1 class medications reduce cardiovascular risk and treat diabetes. But they also allow people to lose an average of 10-20 percent of their body weight in the first year. What does that mean for the overweight or obese?...

World leaders and health experts gathered at the World Economic Forum's annual meeting in Davos to discuss a hypothetical disease X pandemic....

Concern is rising about brain damage young athletes could sustain while playing tackle football....

Having survived after a series of treatments, the sisters are now big advocates for screenings. It's about living beyond cancer and encouraging others to be proactive....

Ozempic and other GLP-1 RA drugs, including Wegovy, Mounjaro and Zepbound, are being scrutinized....

Many people gear up to quit alcohol for a month as part of the "Dry January" challenge. Here's what to know about health benefits as well as terms and tips....

From technology and medicine to the environment, David Progue brings us some of the headlines that remind us 2023 was in many ways a pretty good year!...

Nitazenes are powerful synthetic drugs that, in some cases, can be even more dangerous than fentanyl and carfentanil....

Experts say "Christmas Tree Syndrome" isn't a reaction to the tree itself, but to weed pollen and mold spores collecting on it. Here's what to know about reducing the risk of symptoms....

The prevalence of the JN.1 variant of COVID-19 looks to be highest in New York and New Jersey, where it makes up more than half of cases....